These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1834303)

  • 1. NMDA receptor antagonists block the effects of light on circadian behavior in the mouse.
    Colwell CS; Foster RG; Menaker M
    Brain Res; 1991 Jul; 554(1-2):105-10. PubMed ID: 1834303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do NMDA receptors mediate the effects of light on circadian behavior?
    Colwell CS; Ralph MR; Menaker M
    Brain Res; 1990 Jul; 523(1):117-20. PubMed ID: 2145056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA as well as non-NMDA receptor antagonists can prevent the phase-shifting effects of light on the circadian system of the golden hamster.
    Colwell CS; Menaker M
    J Biol Rhythms; 1992; 7(2):125-36. PubMed ID: 1611128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks.
    Parada-Turska J; Turski WA
    Neuropharmacology; 1990 Dec; 29(12):1111-6. PubMed ID: 2149871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in NMDA receptor antagonist-induced locomotor activity and [3H]MK-801 binding sites in short-sleep and long-sleep mice.
    Velardo MJ; Simpson VJ; Zahniser NR
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1509-15. PubMed ID: 9802536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-response analysis of the behavioral effects of (+)MK-801 in guinea pig: comparison with CPP.
    Jerram AH; Smith PF; Darlington CL
    Pharmacol Biochem Behav; 1996 Apr; 53(4):799-807. PubMed ID: 8801581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX.
    Goettl VM; Larson AA
    Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-D-aspartate antagonist activity of alpha- and beta-sulfallorphans.
    Shukla VK; Lemaire S
    J Pharmacol Exp Ther; 1997 Jan; 280(1):357-65. PubMed ID: 8996216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.
    Kim HS; Rhee GS; Oh S; Park WK
    Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization.
    Ujike H; Tsuchida H; Kanzaki A; Akiyama K; Otsuki S
    Life Sci; 1992; 50(22):1673-81. PubMed ID: 1534132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism by CPP (+/-)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, of beta-phenylethylamine (PEA)-induced hypermotility in mice of different strains.
    Lapin IP
    Pharmacol Biochem Behav; 1996 Oct; 55(2):175-8. PubMed ID: 8951951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase-shifting mechanisms in the mammalian circadian system: new light on the carbachol paradox.
    Colwell CS; Kaufman CM; Menaker M
    J Neurosci; 1993 Apr; 13(4):1454-9. PubMed ID: 7681871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists.
    Torres G; Rivier C
    Brain Res Bull; 1993; 30(1-2):173-6. PubMed ID: 8420627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.
    Yen W; Williamson J; Bertram EH; Kapur J
    Epilepsy Res; 2004 Mar; 59(1):43-50. PubMed ID: 15135166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME; Arnolde SM
    Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 May; 249(2):438-43. PubMed ID: 2542531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents.
    Millan MJ; Gobert A; Bervoets K; Rivet JM; Veiga S; Brocco M
    J Pharmacol Exp Ther; 2000 Feb; 292(2):672-83. PubMed ID: 10640305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The competitive NMDA antagonist CPP blocks MK-801-elicited popping behavior in mice.
    Deutsch SI; Rosse RB; Riggs RL; Koetzner L; Mastropaolo J
    Neuropsychopharmacology; 1996 Oct; 15(4):329-31. PubMed ID: 8887986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system.
    Nehls DG; Kurumaji A; Park CK; McCulloch J
    Neurosci Lett; 1988 Aug; 91(2):204-10. PubMed ID: 2847086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.